BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37591832)

  • 1. One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids.
    Geurts MH; Gandhi S; Boretto MG; Akkerman N; Derks LLM; van Son G; Celotti M; Harshuk-Shabso S; Peci F; Begthel H; Hendriks D; Schürmann P; Andersson-Rolf A; Chuva de Sousa Lopes SM; van Es JH; van Boxtel R; Clevers H
    Nat Commun; 2023 Aug; 14(1):4998. PubMed ID: 37591832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
    Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
    Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new compact adenine base editor generated through deletion of HNH and REC2 domain of SpCas9.
    Qian Y; Wang D; Niu W; Zhao D; Li J; Liu Z; Gao X; Han Y; Lai L; Li Z
    BMC Biol; 2023 Jul; 21(1):155. PubMed ID: 37434184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the base editing scope in rice by using Cas9 variants.
    Hua K; Tao X; Zhu JK
    Plant Biotechnol J; 2019 Feb; 17(2):499-504. PubMed ID: 30051586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Fidelity Cytosine Base Editing in a GC-Rich Corynebacterium glutamicum with Reduced DNA Off-Target Editing Effects.
    Heo YB; Hwang GH; Kang SW; Bae S; Woo HM
    Microbiol Spectr; 2022 Dec; 10(6):e0376022. PubMed ID: 36374037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise in vivo functional analysis of DNA variants with base editing using ACEofBASEs target prediction.
    Cornean A; Gierten J; Welz B; Mateo JL; Thumberger T; Wittbrodt J
    Elife; 2022 Apr; 11():. PubMed ID: 35373735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing.
    Sayed S; Sidorova OA; Hennig A; Augsburg M; Cortés Vesga CP; Abohawya M; Schmitt LT; Sürün D; Stange DE; Mircetic J; Buchholz F
    Cancer Res; 2022 Sep; 82(17):3002-3015. PubMed ID: 35802645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes.
    Liu X; Zhou X; Li G; Huang S; Sun W; Sun Q; Li L; Huang X; Liu J; Wang L
    CRISPR J; 2021 Oct; 4(5):710-727. PubMed ID: 34661426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas9-Mediated Cytosine Base Editing Screen for the Functional Assessment of
    Xiong Y; Xi X; Xiang Y; Li S; Liu H; Su Y; He R; Xiong C; Xu B; Wang X; Fu L; Zhao C; Han X; Li X; Xie S; Ruan J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
    Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
    FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors.
    Chen F; Lian M; Ma B; Gou S; Luo X; Yang K; Shi H; Xie J; Ge W; Ouyang Z; Lai C; Li N; Zhang Q; Jin Q; Liang Y; Chen T; Wang J; Zhao X; Li L; Yu M; Ye Y; Wang K; Wu H; Lai L
    Commun Biol; 2022 Nov; 5(1):1163. PubMed ID: 36323848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors.
    Huang TP; Zhao KT; Miller SM; Gaudelli NM; Oakes BL; Fellmann C; Savage DF; Liu DR
    Nat Biotechnol; 2019 Jun; 37(6):626-631. PubMed ID: 31110355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR single base-editing: in silico predictions to variant clonal cell lines.
    Dickson KA; Field N; Blackman T; Ma Y; Xie T; Kurangil E; Idrees S; Rathnayake SNH; Mahbub RM; Faiz A; Marsh DJ
    Hum Mol Genet; 2023 Aug; 32(17):2704-2716. PubMed ID: 37369005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas nucleases and base editors for plant genome editing.
    Gürel F; Zhang Y; Sretenovic S; Qi Y
    aBIOTECH; 2020 Jan; 1(1):74-87. PubMed ID: 36305010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing.
    Nguyen Tran MT; Mohd Khalid MKN; Wang Q; Walker JKR; Lidgerwood GE; Dilworth KL; Lisowski L; Pébay A; Hewitt AW
    Nat Commun; 2020 Sep; 11(1):4871. PubMed ID: 32978399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications
    Wu S; Li L; Li M; Sun S; Zhao Y; Xue X; Chen F; Zhong J; Guo J; Qu Q; Wang X; Liu Z; Qiao Y
    Front Cell Dev Biol; 2022; 10():809922. PubMed ID: 35300420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internally inlaid SaCas9 base editors enable window specific base editing.
    Jiang L; Long J; Yang Y; Zhou L; Su J; Qin F; Tang W; Tao R; Chen Q; Yao S
    Theranostics; 2022; 12(10):4767-4778. PubMed ID: 35832085
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
    Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
    Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation.
    Jeon W; Jung SY; Lee CY; Kim WT; Kim H; Jang KW; Lim H; Lee M; Jeong DH; Kim SD; Kim IA; Choi SH; Son TG; Kim KS
    Technol Cancer Res Treat; 2023; 22():15330338231165125. PubMed ID: 36960537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.